Model DetailsOviduct hyperplasia
Model Name |
Oviduct hyperplasia | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Chemical/Drug : tamoxifen (TAM) |
Tumor Synonyms |
oviduct hyperplasia • progressive proliferative lesion of the oviduct (PPL) |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Oviduct | Female |
30% (3 of 10 mice) |
12 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
50% (5 of 10 mice) |
24 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
100% (15 of 15 mice) |
52 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
100% (23 of 23 mice) |
53-78 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
50% (5 of 10 mice) |
12 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
80% (8 of 10 mice) |
24 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
100% (15 of 15 mice) |
52 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
100% (22 of 22 mice) |
53-78 weeks |
|
Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
| Oviduct | Female |
100% (17 of 17 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
93% (14 of 15 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (9 of 9 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (11 of 11 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (11 of 11 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (10 of 10 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
86% (30 of 35 mice) |
90 weeks |
|
Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |